Rob is an Investment Director responsible for originating, evaluating and executing transactions.

Rob has been involved in our investments in Systal, Sparta Global, Goals, Infront, Medivet, K2 Partnering Solutions, PMC Treasury, CNX Therapeutics, Proteros, Nomentia and aosphere.

He started his career in strategy consulting at Monitor Deloitte, working on a range of corporate and digital strategy projects in the TMT sector. Prior to joining Inflexion in 2019, he was with a venture capital fund, specialising in investments into software and media businesses.

Outside work, Rob continues to find time to play basketball and is a keen watcher of all sports, particularly rugby, cricket and Arsenal.

Rob holds a BSc in Management from the London School of Economics and is a CFA charterholder.